AKBA FY 2014 Earnings — Akebia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AKBAAkebia Therapeutics, Inc.

$375M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$23M

Operating Income

-$38M

Net Income

-$37M

EPS (Diluted)

$-2.40

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$28M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$111M

Total Liabilities

$7M

Stockholders' Equity

$104M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$23M	$0	—
Operating Income	-$38M	-$16M	-138.1%
Net Income	-$37M	-$13M	-181.3%